yahoo Press
Redwire Corporation (RDW): NASA Awards Additional $4 million to Support New Drug Development Investigations
Images
Redwire Corporation (NYSE:RDW) is one of the 12 Most Shorted Stocks to Buy in 2026. On March 11, the company announced that NASA awarded an additional $4 million towards supporting new drug development investigations on the International Space Station (ISS) using Redwire Corporation (NYSE:RDW)’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. As a result of this additional funding, there has been an expansion of existing task order under $25 million, 5-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. Notably, NASA and the InSPA program continue to act as a catalyst for the revolutionary new public and private sector capabilities. In a different update, on March 9, Truist upgraded the company’s stock to “Buy” from “Hold” with a price objective of $15, up from the prior target of $13. As per the analyst, improvement in mix and progress on programs, along with development programs, gives visibility that equivalent annual cost charges will moderate over the upcoming periods. The firm added that Redwire Corporation (NYSE:RDW)’s new CFO announced low and achievable targets for 2026. Redwire Corporation (NYSE:RDW) offers critical space solutions and space infrastructure for government and commercial customers. While we acknowledge the potential of RDW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts. Disclosure: None. Follow Insider Monkey on Google News.